Leidos successfully completes second test launch for MACH-TB program
RESTON, Va. (Dec. 9, 2024) – Leidos announced it has successfully completed a commercial launch vehicle test for the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) program in November. The MACH-TB program is designed to increase the speed of testing using commercially available hypersonic launch systems.
“The success of this launch marks an important milestone for our hypersonic testing services,” said Larry Barisciano, aerospace systems lead for Leidos. “The program’s goal is to consistently and rapidly test various payloads to help the government assess technical readiness levels of advanced hypersonic capabilities. This launch serves as a testament to the speed in which Leidos could pull the program together, highlighting the agility Leidos provides for customers.”
George Rumford, director of the U.S. Department of Defense Test Resource Management Center, stated, “Leveraging commercial launch services allows our nation to affordably test components early and frequently, accelerating hypersonic development.”
The project was awarded to Leidos by Naval Surface Warfare Center Crane through the Strategic and Spectrum Missions Advanced Resilient Trusted Systems Other Transaction Authority vehicle on behalf of the U.S. Department of Defense Test Resource Management Center.
About Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health. The company's global workforce of 48,000 collaborates to create smarter technology solutions for customers in heavily regulated industries. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $15.4 billion for the fiscal year ended December 29, 2023. For more information, visit www.leidos.com.
Certain statements in this announcement constitute “forward-looking statements” within the meaning of the rules and regulations of the U.S. Securities and Exchange Commission (SEC). These statements are based on management’s current beliefs and expectations and are subject to significant risks and uncertainties. These statements are not guarantees of future results or occurrences. A number of factors could cause our actual results, performance, achievements, or industry results to be different from the results, performance, or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, the “Risk Factors” set forth in Leidos’ Annual Report on Form 10-K for the fiscal year ended December 29, 2023, and other such filings that Leidos makes with the SEC from time to time. Readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. Leidos does not undertake to update forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statements were made.
